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ABSTRACT
The measurement and examination of adverse events
(AEs) that occur in children during hospital admissions
is essential if we are to prevent, reduce or ameliorate
the harm experienced. The UK Paediatric Trigger Tool
(UKPTT) is a method of retrospective case note review
that measures harm in hospitalised children.
Objectives: To examine the harm resulting from the
processes of healthcare in hospitalised children from
centres providing data to the National Health Service
(NHS) Institute UKPTT data portal, to understand the
positive predictive values of triggers and to make
recommendations for the further development of the
trigger tool.
Setting: 25 hospitals across the UK, including
secondary, tertiary and quaternary paediatric centres.
Participants: Randomly selected children who were
admitted to hospital for longer than 24 h.
Outcome measures: The primary outcome measure
was the rate of harm (the percentage of children
experiencing one or more AEs during a hospital
admission). Secondary measures were the severity of
harm and performance of triggers.
Results: Data from 3992 patient admissions were
reviewed across the hospitals and submitted to the
trigger tool portal from February 2008 to November
2011. At least one AE was reported for 567 (14.2%)
patients, with 211 (5.3%) experiencing more than one
event. There were 1001 AEs identified. Where harm
occurred, it was considered temporary for 923 (92.2%)
AEs; however, 43 (4.3%) AEs resulted in the need for
life-sustaining interventions, 18 (1.8%) AEs led to
permanent harm and for 17 children (1.7% of AEs) the
AE was believed to have contributed to death.
Conclusions: There is a significant, measurable level
of harm experienced by children admitted to hospitals
in the UK. While most of this harm is temporary, some
of it is serious. The UKPTT offers organisations the
means to measure and examine the AEs occurring in
their hospital in order to reduce harm.
INTRODUCTION
The provision of care that is safe and reliable
is a fundamental goal of modern healthcare.
Patient safety is the prevention, reduction
and amelioration of medical harm.1 2
Medical harm (synonymous with the terms
patient harm and adverse event, AE) is
deﬁned as unintended physical injury result-
ing from or contributed to by medical care
that requires additional monitoring, treat-
ment or hospitalisation or that results in
death.3 Efforts to improve patient safety have
been hampered by a lack of reliable data on
the prevalence and nature of harm in all
areas of practice. Patients and healthcare
professionals need to understand the burden
of harm in healthcare in order to develop
effective interventions.4
DEVELOPMENT OF TRIGGER TOOL
METHODOLOGY
The Global Trigger Tool (GTT) for measur-
ing harm was developed by the Institute for
Healthcare Improvement for use in adult
care settings.3 Trigger tools have also been
developed for speciﬁc populations and set-
tings, including acute hospitals, surgery,5 crit-
ical care6 and primary care.7 One study used
the GTT to measure harm at a large aca-
demic children’s hospital in the USA and
recommended the development of a paediat-
ric speciﬁc tool.8 Paediatric-speciﬁc trigger
tools have been developed for neonatology,9
paediatric critical care,10 11 medications12 13
Strengths and limitations of this study
▪ This study estimates that one in seven children
experience harm during admission to hospital in
the UK. Most of this harm is temporary, but a
significant minority is serious. This should gen-
erate discussion about patient safety in
paediatrics.
▪ The study used the UK Paediatric Trigger Tool
that can be used by any hospital to learn about
harm in order to prevent or reduce it.
▪ The study does not distinguish between prevent-
able and non-preventable harm; however, we
believe that there is an opportunity to learn from
any harm event.
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and a general trigger tool for harm in hospitalised chil-
dren.14 A UK version of the acute adult GTT had
already been developed, but this was not applicable to a
paediatric population. In 2008, the National Health
Service (NHS) Institute for Innovation and
Improvement undertook to develop a UK Paediatric
Trigger Tool (UKPTT) that could be applied to all levels
of acute paediatric care.
TRIGGER TOOL METHOD FOR REVIEWING CASE NOTES
The trigger tool method is a retrospective review of 20
sets of healthcare records each month, using a standar-
dised methodology. A random sample of 20 inpatient
case notes is selected using a randomisation matrix on a
monthly basis. The healthcare record is examined in a
structured process for 20 min to search for ‘triggers’. A
‘trigger’ is a predeﬁned event that alerts the reviewer to
the possibility of patient harm. Once a trigger is identi-
ﬁed, the reviewer uses clinical expertise to examine the
records in more detail to understand the circumstances
around the event. If harm is suspected, a second
reviewer (usually a physician) is consulted to conﬁrm
and grade the AE using the National Coordinating
Council for Medication Error Reporting and Prevention
(NCC MERP) grading system (table 4).15
An example of a trigger is the administration of the
antidote medication naloxone (a trigger) to reverse the
effects of opiates. This alerts the reviewer to a possible
overdose of opioids. The reviewer examines the relevant
parts of the healthcare record to assess whether the use
of naloxone was for this reason or not. If this is the
reason, then the harm is graded (see online supplemen-
tary ﬁle).
DEVELOPMENT OF THE UKPTT
In 2008, the NHS Institute sponsored the development
of a Paediatric Trigger Tool because at the time there
was no tool available for hospitalised children. The tool
design was informed by the early (and prepublication)
ﬁndings of a Canadian Paediatric Trigger Tool (CPTT)
study,14 and the UK Acute Trigger Tool for adults.16 The
development was a coproduction involving the collabor-
ation of patient safety experts from the NHS Institute,
international leaders in Paediatric Trigger Tool develop-
ment, and clinical experts from nine UK hospitals
including children’s hospitals and district general hospi-
tals. Following discussion and testing, the group agreed
on 40 paediatric oriented triggers to be included in the
UKPTT. These were based on the triggers used in other
tools, UK evidence of AEs and the experience of the ref-
erence group in harm and AEs (a subset of the
coproduction group). Production of a UK tool was
intended to enhance ownership by the clinicians, who
would use it in practice and to modify triggers that were
not appropriate for the UK setting. We also added a cat-
egory for ‘other harm’ to capture harm that was not
detected by one of the listed triggers.
The UKPTT advocates a working deﬁnition of patient
harm as ‘anything, which you would not like to happen
to yourself or a member of your family as a result of, or
contributed to by, medical care’. The decision to aim for
a broad deﬁnition was to focus on the patient rather
than on the medical system—a less defensive approach.
This is a broader deﬁnition than that given by Grifﬁn
and Resar3 or the Canadian tool and aimed to encour-
age clinicians to explore a holistic concept of harm than
that traditionally reported. It allows the inclusion of acts
of omission as well as commission. The deﬁnition
includes missed or delayed diagnosis along with physical
and psychological harm.
Through the coproduction, support was developed for
UKPTT users such as face-to-face training, online and
printed guidance and standardised data collection
forms.
DATA COLLECTION
As part of the UKPTT development, the NHS Institute
created a web-based trigger tool portal into which par-
ticipating hospitals entered anonymised data. The portal
calculated harm rates and produced run charts that hos-
pitals could download. Contributing hospitals consented
to their data being collated and published to further the
understanding of harm in hospitalised children in the
UK. Participating hospitals developed local administrative
and governance arrangements for PTT reviews following
the standard guidance (see online supplementary ﬁle).
AIMS AND METHODOLOGY
The aims of this study are to:
1. Describe the rate and severity of harm occurring in
hospitalised children from UK centres submitting
data to the NHS Institute’s Trigger Tool portal.
2. Report the frequency and positive predictive value
(PPV) of triggers to detect harm.
3. Make recommendations for further application and
development of the tool.
Participating hospitals, which voluntarily decided to
use the PTT, included secondary, tertiary and quaternary
centres. Reviewers were trained in trigger tool method-
ology either by experts at the NHS Institute or by using
online resources with telephone support. Data were col-
lected through the online trigger tool portal that
opened in February 2008.
RESULTS
Data from 3992 case note reviews from 25 hospitals sub-
mitted to the trigger tool portal between February 2008
and November 2011 were analysed. Nine of the hospitals
were children’s hospitals; the remainder was classed as
district general hospitals. Data from four additional hos-
pitals that used the portal were excluded because they
each submitted less than 10 case entries. Harm was
recorded as occurring for 567 patients (14.2%) while
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the majority (85.8%) of patients experienced no evi-
dence of harm. Reviewers identiﬁed 1001 AEs, an
average of 1.8 events per patient experiencing harm.
There was considerable variation between hospitals in
the number of case notes reviewed (12–622), the
number of triggers detected (17–1877) and the overall
harm rate reported (0—73.3%). Results from each hos-
pital are reported in table 1. Of the 567 children who
suffered an AE, the majority (n=356, 63%) experienced
a single event. However, 211 (37%) patients suffered
more than one AE within the same admission. One
patient was reported to have suffered 10 AEs in a single
admission. A summary of the number of AEs per case is
presented in table 2.
Individual triggers varied in their ability to lead to
detection of harm. The trigger Complications of procedure
or treatment yielded the greatest amount of harm (182
AEs). The PPV varied from 80.0% for surgical site infec-
tion to 2.62% for missing observations/early warning scores.
Also, the PPV was generally low in frequently identiﬁed
triggers, such as missing observations/early warning scores
(PPV 2.6%) and unplanned admission (PPV 4%). The
positive triggers, AEs and PPV for each trigger are dis-
played in table 3.
The majority of AEs (n=923, 92.2%) resulted in tempor-
ary harm to the patient (grades E and F—see table 515);
43 AEs required life-sustaining interventions and 18
resulted in permanent harm. In 17 cases, the AE was
believed to have contributed to the child’s death (table 4).
DISCUSSION
The complexity of uncovering harm is reﬂected in the
numerous ways that one has to measure it.17 Traditional
methods such as incident reporting have limitations,
especially that of under-reporting, due to the reliance on
individual clinicians to recognise and report AEs, as well
as a tendency to focus on error rather than on harm. The
measurement and examination of harm, rather than that
of error, recognises that efforts to improve patient safety
beneﬁt from focusing on incidents that result in actual
harm, identifying high-risk situations, considering pre-
ventability and looking for means of early detection and
harm limitation.18 This deeper understanding of the
harm to which patients are exposed is a recent phenom-
enon and in paediatrics the potential risks to safety are
multiple.19 The call for zero harm and the focus on safety
in recent reports20 21 reﬂect the importance of the identi-
ﬁcation and understanding of harm as an essential part
of patient care. Clinicians have not known the actual
levels of harm caused and have relied on a reporting
system for clinical incidents.
Harm rates vary widely because of multiple factors,
such as the deﬁnition of harm used, the methodology
Table 1 Number of case reviews, positive triggers and adverse events by individual hospital
Hospital
Case notes
reviewed
Positive
triggers
Average number of
triggers per case
note review
Adverse
events (AEs)
Average number of
AEs per case note
review
Number of
individual patients
harmed (%)
A 622 1877 3.02 309 0.50 162 (26)
B 369 579 1.57 66 0.18 31 (8)
C 321 415 1.29 60 0.19 37 (11.5)
D 309 481 1.56 117 0.38 49 (15.9)
E 285 414 1.45 84 0.29 43 (15.1)
F 271 454 1.68 112 0.41 54 (20)
G 260 484 1.86 48 0.18 39 (15)
H 241 418 1.73 6 0.02 4 (1.7)
I 195 432 2.22 14 0.07 14 (7.2)
J 195 52 0.27 3 0.02 3 (1.5)
K 190 446 2.35 45 0.24 40 (21)
L 124 173 1.40 17 0.14 15 (12.1)
M 71 52 0.73 0 0.00 0 (0)
N 70 171 2.44 8 0.11 7 (10)
O 68 141 2.07 8 0.12 7 (10.3)
P 68 107 1.57 1 0.01 1 (1.5)
Q 66 79 1.20 15 0.23 11 (16.7)
R 62 84 1.35 15 0.24 12 (19.3)
S 60 121 2.02 32 0.53 15 (25)
T 59 90 1.53 2 0.03 1 (1.7)
U 23 22 0.96 4 0.17 3 (13)
V 19 14 0.74 1 0.05 1 (5.2)
W 17 26 1.53 4 0.24 4 (23.5)
X 15 50 3.33 27 1.80 11 (73.3)
Y 12 17 1.42 3 0.25 3 (25)
Overall 3992 7199 1.65 1001 0.26 567 (14.2)
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employed and the population studied. Until recently,
most studies sought to establish harm rates for bench-
marking purposes over large populations with sugges-
tions that between 3% and 17% of patients experience
an AE during a hospital admission.22 Most of these
studies used retrospective, unstructured case note
reviews which are labour-intensive, costly and impractical
for the routine monitoring of harm.23 Trigger tool meth-
odology is accepted as one of the ways to measure harm
in a way that allows local learning,1 3 2 Trigger tools have
also been reported to provide consistent, reliable and
relevant data at low cost,2 3 although the cost may vary
between different hospitals.
This paper represents the largest study of paediatric
harm using trigger tool methodology in the UK. While
the primary purpose of a trigger tool is to gain local data
for understanding harm in order to improve patient
safety locally, we can learn about harm by examining the
pooled experiences of the contributing hospitals.
The overall harm rate (the percentage of individual
children experiencing one or more AEs during an
admission) identiﬁed in this study was 14.2%. Previous
studies focusing on hospitalised children have identiﬁed
harm rates between 1% and 25.8% per admission for
the general paediatric hospital population,12 13 18 and
higher rates within the paediatric intensive care popula-
tion of 26.1% to 62%.10 11 24 Two recent studies have
examined harm in paediatric hospital populations using
trigger tool methodology. The CPTT found a physician
who reported a harm rate of 15.1% of admissions
during a validation study across six paediatric hospitals
in Canada.25 Like the UKPTT, the CPTT has been
adapted to make triggers more sensitive and speciﬁc to
paediatric settings. The second study, at a single paediat-
ric academic medical centre in the USA using the adult
GTT, found an overall harm rate of 25.8%.8
Variation in harm rates may reﬂect a number of
factors. Different methodologies yield different rates of
AE identiﬁcation. Trigger tools are reported to yield
higher rates of AE identiﬁcation than traditional
methods such as self-reporting and unstructured case
note review.1 24 Deﬁnitions of harm vary, as do their
interpretation. Professional groups may interpret AEs
differently.26 Assessments of inter-rater reliability have
reported high levels of agreement between review team
members,8 26 27 but there is variability between different
hospital department teams.28 In addition, some organi-
sations or teams set a lower threshold for what they see
as harm and they may change this over time. Finally, dif-
ferent populations are exposed to different levels of
harm depending on the complexity of their illness and
the intensity and duration of their care.2 Most studies
report a harm rate per admission, meaning that longer
admissions are more exposed to opportunity for harm.
The same reasons that explain the variation between
international studies also explain much of the variation
between hospitals in this study. Training was provided,
but no independent assessment was made of the
reviewer’s interpretations or competence. The extremes
of harm reported or its absence were seen in hospitals
uploading low volumes of reviews and may be inter-
preted as the relative inexperience of the reviewers.29
There is also a wide variety across the level of hospital
represented with the corresponding impact on risk due
to patient complexity, need for surgery or critical care
and length of stay. While we had no means of adjusting
for acuity because of the random selection of notes from
within hospitals, we believe that the overall group is
broadly representative of the population of hospitalised
children in the UK.
One could ask whether this level of variation diminishes
the ﬁndings of the study. On the contrary, we believe it
represents a real portrayal of complex issues. It is also a
taste of what individual organisations can expect if they
start to use the PTT to help understand and reduce the
harm in their institution. They will need to consider all of
these issues as they interpret their own ﬁndings.
The majority (92.3%) of AEs identiﬁed in this study
represented temporary harm resulting in the child
requiring an intervention, admission to hospital or pro-
longation of their hospital stay. While severe harm (per-
manent harm or harm that required life-sustaining
measures or contributed to death) was rare, it still consti-
tuted 7.8% of the harm identiﬁed. Similar ﬁndings with
respect to severity have been reported with 10% of AEs
classiﬁed as severe in one study of harm in a paediatric
intensive care unit.10 A study of AEs in hospitalised chil-
dren reported that clinicians do not always recognise
harm, even when the consequences to the child are
severe.30 In this study, multiple AEs were relatively
common, with 37% of those experiencing harm suffer-
ing two or more AEs in the same admission, far higher
than in previous studies.8 25
Triggers varied in their PPV for AEs. Screening for
triggers is the key task of the trigger tool method.
Triggers that infrequently identify harm could be
removed to increase the efﬁciency of the tool. Some trig-
gers may be important markers of care quality, such as
Table 2 Number of AEs per patient
Number of
AEs per
case
Number of
patients
(n=3992)
Proportion (%) of
patients experiencing
one or more AEs
(n=567)
0 3425 NA
1 356 62.8
2 111 19.6
3 40 7.0
4 28 4.9
5 16 2.8
6 8 1.4
7 5 0.9
9 2 0.4
10 1 0.2
AEs, adverse events; NA, not applicable.
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the missing/incomplete early warning score or baseline observa-
tions, despite the inability of the trigger to identify spe-
ciﬁc patient harm.31 This will inﬂuence the next
iteration of the trigger tool as we reﬁne the triggers and
consider taking out some of those that had a low PPV.
A number of studies have examined the possibility of
automated trigger detection from electronic medical
records, which may make the process easier.13 32 We
believe that there is value in the manual approach, and
that it will be some time before paper-based medical
records in hospitals in the UK are converted to elec-
tronic medical records. Users of the UKPTT have
expressed to us the beneﬁts of having an opportunity to
examine the quality of medical and nursing note
keeping and observations, which in some centres has
resulted in initiatives to improve these elements.
Table 3 Trigger descriptors, AE and positive predictive value
Trigger
Code Trigger description
Adverse
events
Positive
triggers
Severity of harm Trigger
PPV (%)E F G H I
PG8 Complication of procedure or treatment 182 257 99 63 6 11 3 70.8
PG3 Readmission to hospital within 30 days 107 462 36 68 0 1 2 23.2
PG2 Tissue damage or pressure ulcer 81 250 66 12 0 1 2 32.4
PG4 Unplanned admission 68 1668 23 41 0 3 1 4.1
PO1 Other (specify) 60 425 48 10 0 1 1 14.1
PS3 Surgical site infection 48 60 24 22 0 1 1 80.0
PM5 Anti-emetic given 41 507 40 1 0 0 0 8.1
PG10 Hypoxia O2 sat <85% 36 157 31 2 3 0 0 22.9
PG1 EWS or baseline observations missing/incomplete
or score/observation requiring response
35 1362 26 8 0 1 0 2.6
PG9 Transfer to higher level of care (inc admission to
specialist unit, ICU/HDU)
35 273 15 14 0 5 1 12.8
PS1 Return to theatre 33 75 15 15 2 1 44.0
PM7 Intravenous bolus≥10 mL/kg colloid or crystalloid
given
31 386 22 5 1 1 2 8.0
PG11 Cancelled elective procedure/ delayed discharge 24 55 10 12 1 0 1 43.6
PL14 Positive blood culture 23 55 18 4 0 1 0 41.8
PL13 Nosocomial pneumonia 21 28 8 10 0 2 1 75.0
PL5 Na+ <130 or >150 14 71 12 1 0 1 0 19.7
PG5 Cranial imaging 10 141 4 2 3 0 1 7.0
PL8 Hyperglycaemia (>12 mmol/L) 11 65 10 1 0 0 0 16.9
PS2 Change in planned procedure 11 37 6 5 0 0 0 29.7
PL3 Abrupt drop in Hb or Hct (>25%) 10 65 9 1 0 0 0 15.4
PM8 Abrupt medication stop 10 52 8 2 0 0 0 19.2
PL8 Hypoglycaemia (<3 mmol/L) 10 46 9 1 0 0 0 21.7
PL9 Drug level out of range 10 32 8 2 0 0 0 31.3
PL6 K+ <3.0 or >6.0 9 69 8 0 0 1 0 13.0
IP1 Readmission to ICU or HDU 9 16 5 1 0 3 0 56.3
PS4 Removal/injury or repair of organ 9 43 3 5 1 0 0 20.9
PG6 Respiratory/cardiac arrest/crash call 9 41 0 2 0 7 0 22.0
PM5 Chlorpheniramine given 9 82 7 2 0 0 0 11.0
PL2 Transfusion 8 143 6 1 0 1 0 5.6
PL4 Rising urea or creatinine (>2× baseline) 6 54 4 2 0 0 0 11.1
PL15 Thrombocytopenia 6 54 4 1 0 0 1 11.1
PL1 High INR (>5) or APTT>100 s 6 31 6 0 0 0 0 19.4
PM4 Glucagon or glucose≥10% given 6 50 6 0 0 0 0 12.0
PG7 Diagnostic imaging for embolus/thrombus
+/− confirmation
4 24 2 1 1 0 0 16.7
PM2 Naloxone given 4 16 3 0 0 1 0 25.0
PL11 Clostridium difficile 4 12 3 1 0 0 0 33.3
PM1 Vitamin K given (except routine neonatal dose) 1 33 1 0 0 0 0 3.0
PM3 Flumazanil given 0 2 0 0 0 0 0 NA
PL10 MRSA bacteraemia 0 0 0 0 0 0 0 NA
PL12 Vancomycin-resistant enterococcus 0 0 0 0 0 0 0 NA
TOTAL 1001 7199 605 318 18 43 17
AE, adverse events; APTT, activated partial thromboplastin time; Hb, haemoglobin; Hct, haematocrit; HDC, high dependency unit; ICU,
intensive care unit; INR, international normalised ratio; MRSA, methicillin-resistant Staphylococcus aureu; NA, not applicable; PPV, positive
predictive value.
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LIMITATIONS
There are a number of limitations to this study. The val-
idity of trigger tool methodology is well established and
we did not attempt to revalidate it again against another
form of medical notes review for harm, as we did not
believe this was necessary. The UKPTT differs from
other trigger tools only in the constituent triggers. This
study has provided PPVs for the 40 triggers included in
the UKPTT. This validates the choice of high perform-
ing triggers and raises questions about the continued
inclusion of low performing ones, which may be used to
consider changes to the trigger proﬁle. New triggers
may also be suggested and could be tested for future ver-
sions of the tool.
The determination of inter-rater reliability may be
important within departments but not necessarily
between hospitals. The UKPTT is not recommended for
benchmarking as the focus is on developing data for
improvement rather than data for judgement.33 The
methodology recommends consistency in the reviewing
teams so that intrareliability is not an issue.34 We did not
attempt to standardise the method of PTT data collec-
tion outside of the support provided and the recommen-
dation on randomisation. Individual institutions made
their own arrangements in terms of choosing and train-
ing reviewers. There were no checks of competence of
reviewers or inter-rater reliability or of the accuracy of
the data entered via the portal.
STRENGTHS
Parry et al35 note that the approach should be to look at
all harm, not only preventable harm. It is our belief that
the ability to measure harm and examine case notes
using the UKPTT on a regular basis is an effective
method of data capture and analysis, which provides hos-
pitals with valuable insights into their quality of care, as
every AE provides insight for improvement, whether
deemed preventable or not.10
We did not attempt to ﬁnd out how many of these AEs
were detected through other methods, such as incident
reporting (we expect that many were). The purpose of
the UKPTT is to extend the ability to detect harm rather
than to replace other approaches.
CONCLUSIONS AND RECOMMENDATIONS
In the context of the increasing demands to improve
quality and safety for patients, the UKPTT provides a
framework for paediatric clinicians to assess the rate of
harm for their individual units, and the quality of their
record keeping. This study highlights that currently
there is a signiﬁcant, measurable level of harm, which is
sometimes severe, experienced by children admitted to
hospitals in the UK. There is a range of predictive values
for the triggers and some may be more useful than
others. These ﬁndings will inform future modiﬁcations
of the PTT including modifying or removing triggers. It
will be important to test any new or augmented triggers
with paediatric teams to assess their usefulness.
The recognition and examination of AEs through
methods such as the UKPTT offers the potential to
improve paediatric patient safety by concentrating
efforts on strategies that reduce patient harm, rather
than errors. The key is to produce information that pro-
motes learning and improvement, with clinicians accept-
ing their role to decrease harm from the perspective of
the patient, rather than that of the healthcare provider.
We recommend that the UKPTT be used routinely in
hospitals to assess harm and to help develop improve-
ment interventions to reduce it. Although the PTT has
been mainly used in children’s hospitals, it can be used
in district general or community hospitals, with a differ-
ent spectrum of harm being detected. The UKPTT does
not replace other reporting mechanisms, but is a useful
addition to the methods already used to understand the
harm caused to children in hospital care. Harm needs to
be detected and assessed through a number of lenses
and this lens allows clinicians to further understand what
they do and how harm impacts on children. It provides a
way to move from a reactive approach to safety to one
that is more proactive and founded on harm free care.
Author affiliations
1Department of Paediatrics, Great Ormond Street Hospital
for Children NHS Foundation Trust, London, UK
2University College London, London, UK
3Department of Paediatrics, Our Lady of Lourdes Hospital, Drogheda, Ireland
4Quality & Patient Safety Division, Health Service Executive, Dublin, Ireland
5NHS Institute for Innovation and Improvement, University of Warwick
Science Park, Coventry, UK
Table 4 Severity of adverse events
NCC MERP
Grade15 Descriptor
Adverse
events
Total adverse
events (%)
E Temporary harm to the patient and required intervention 605 60.4
F Temporary harm to the patient and required initial or prolonged admission 318 31.8
G Permanent patient harm 18 1.8
H Intervention required to sustain life 43 4.3
I Patient death 17 1.7
Total 1001
National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) Index.23
6 Chapman SM, Fitzsimons J, Davey N, et al. BMJ Open 2014;4:e005066. doi:10.1136/bmjopen-2014-005066
Open Access
group.bmj.com on February 20, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
Acknowledgements The authors would like to thank Matt Tite at the National
Health Service (NHS) Institute for Innovation and Improvement for extracting
and processing the data. The authors would also like to thank all the
participating institutions whose unidentifiable data have been made available
for the analysis, and those who participated in the development of the UKPTT.
Contributors SMC were involved in the development of the Paediatric Trigger
Tool, study concept, data collection, data analysis and manuscript preparation.
JF involved in the development of paediatric trigger tool, study concept, data
analysis and manuscript preparation. ND involved in the development of
paediatric trigger tool, study concept, data collection, data analysis and
manuscript revision. PL involved in the development of paediatric trigger tool,
study concept, data analysis and manuscript revision.
Funding National Health Service (NHS) Institute for Innovation and
Improvement.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/3.0/
REFERENCES
1. Resar RK, Rozich JD, Classen D. Methodology and rationale for the
measurement of harm with trigger tools. Qual Saf Health Care
2003;12(Suppl 2):ii39–45.
2. Beyea SC. Using trigger tools to enhance patient safety. AORN J
2005;82:115–16.
3. Griffin FA, Resar RK. IHI Global Trigger Tool for measuring adverse
events. 2nd edn. IHI Innovation Series white paper. Cambridge, MA:
Institute for Healthcare Improvement, 2009.
4. Classen DC, Resar RK. The burden of harm. Jt Comm J Qual
Patient Saf 2013:39:291.
5. Griffin FA, Classen DC. Detection of adverse events in surgical
patients using the Trigger Tool approach. Qual Saf Health Care
2008;17:253–8.
6. Resar RK, Rozich JD, Simmonds T, et al. A trigger tool to identify
adverse events in the intensive care unit. Jt Comm J Qual Patient
Saf 2006;32:585–90.
7. Singh RN, McLean-Plunckett EA, Kee R, et al. Experience with a
trigger tool for identifying adverse drug events among older adults in
ambulatory primary care. Qual Saf Health Care 2009;18:199–204.
8. Kirkendall ES, Kloppenborg E, Papp J, et al. Measuring adverse
events and levels of harm in pediatric inpatients with the Global
Trigger Tool. Pediatrics 2012;130:e1206–14.
9. Sharek PJ, Horbar JD, Mason W, et al. Adverse events in the
neonatal intensive care unit: development, testing, and findings of an
NICU-focused trigger tool to identify harm in North American NICUs.
Pediatrics 2006;118:1332–40.
10. Larsen GY, Donaldson AE, Parker HB, et al. Preventable harm
occurring to critically ill children. Pediatr Crit Care Med
2007;8:331–6.
11. Agarwal S, Classen D, Larsen G, et al. Prevalence of adverse
events in pediatric intensive care units in the United States. Pediatr
Crit Care Med 2010;11:568–78.
12. Takata GS, Mason W, Taketomo C, et al. Development, testing, and
findings of a pediatric-focused trigger tool to identify
medication-related harm in US children’s hospitals. Pediatrics
2008;121:e927–35.
13. Muething SE, Conway PH, Kloppenborg E, et al. Identifying causes
of adverse events detected by an automated trigger tool through
in-depth analysis. BMJ Qual Saf 2010;19:435–9.
14. Matlow AG, Cronin CMG, Flintoft V, et al. Description of the
development and validation of the Canadian Paediatric Trigger Tool.
BMJ Qual Saf 2011;20:416–23.
15. http://www.nccmerp.org/medErrorCatIndex.html (accessed 25 May
2014).
16. Carter M. Measuring harm levels with the Global Trigger Tool.
Clinical Risk 2010;16:122–6.
17. Thomas EJ, Petersen LA. Measuring harm and adverse events in
healthcare. J Gen Intern Med 2003;18:61–7.
18. Woods D, Thomas E, Holl J, et al. Adverse events and preventable
adverse events in children. Pediatrics 2005;115:155–60.
19. Review of patient safety for children and young people. National
Patient Safety Agency 2009. http://www.nrls.npsa.nhs.uk/resources/
?entryid45=59864 (accessed 25 May 2014).
20. Mid Staffordshire NHS Foundation Trust Public Inquiry. Report of the
Mid Staffordshire NHS Foundation Trust Public Enquiry Feb 2013.
http://www.midstaffspublicinquiry.com/report. (accessed 25 May
2014).
21. National Advisory Group on the Safety of Patients in England. A
Promise to Learn a Committment to Act-Improving the safety of
patients in England. 2013. https://www.gov.uk/government/uploads/
system/uploads/attachment_data/file/226703/Berwick_Report.pdf
(accessed 25 May 2014).
22. Sari ABA, Sheldon TA, Cracknell A, et al. Sensitivity of routine
system for reporting patient safety incidents in an NHS hospital:
retrospective patient case note review. BMJ 2007:334:79.
23. Tinoco A, Evans RS, Staes CJ, et al. Comparison of computerized
surveillance and manual chart review for adverse events. J Am Med
Inform Assoc 2011;18:491–7.
24. Silas R, Tibballs J. Adverse events and comparison of systematic
and voluntary reporting from a paediatric intensive care unit. Qual
Saf Health Care 2010;19:568–71.
25. Matlow AG, Baker GR, Flintoft V, et al. Adverse Events among
children in Canadian hospitals: the Canadian Paediatric Adverse
Events Study. CMAJ 2012;184:E709–18).
26. Naessens JM, O’Byrne TJ, Johnson MG, et al. Measuring hospital
adverse events: assessing inter-rater reliability and trigger
performance of the Global Trigger Tool. Int J Qual Health Care
2010;22:266–74.
27. Sharek PJ, Parry GJ, Goldmann D, et al. Performance
characteristics of a methodology to quantify adverse events over
time in hospitalized patients. Health Serv Res 2011;46:654–78.
28. Zegers M, de Bruijne MC, Spreeuwenberg P, et al. Variation in the
rates of adverse events between hospitals and hospital
departments. Int J Qual Health Care 2011;23:126–33.
29. Zegers M, de Bruijne MC, Wagner C, et al. The inter-rater
agreement of retrospective assessments of adverse events does not
improve with two reviewers per patient record. J Clin Epidemiol
2010;63:94–102.
30. Woods DM, Holl JL, Shonkoff JP, et al. Child-specific risk factors
and patient safety. J Patient Saf 2005;1:17–22.
31. NHS Outcomes Framework 2012/13, Technical details of indicators.
2011: Section5.6:92. https://www.gov.uk/government/uploads/
system/uploads/attachment_data/file/213713/dh_131721.pdf
(accessed 25 May 2014).
32. Lemon V, Stockwell DC. Automated detection of adverse events in
children. Pediatr Clin North Am 2012;59:1269–78.
33. Solberg LI, Mosser G, McDonald S. Three faces of performance
measurement. J Qual Improv 1997:23:135–47.
34. Landrigan CP, Parry GJ, Bones CB, et al. Temporal trends in rates
of patient harm resulting from medical care. N Engl J Med
2010;363:2124–34.
35. Parry GJ, Cline A, Goldmann DA. Deciphering harm measurement.
JAMA 2012;307:2155–6.
Chapman SM, Fitzsimons J, Davey N, et al. BMJ Open 2014;4:e005066. doi:10.1136/bmjopen-2014-005066 7
Open Access
group.bmj.com on February 20, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
by the Paediatric Trigger Tool
sample of UK-hospitalised children detected 
Prevalence and severity of patient harm in a
Susan M Chapman, John Fitzsimons, Nicola Davey and Peter Lachman
doi: 10.1136/bmjopen-2014-005066
2014 4: BMJ Open 
 http://bmjopen.bmj.com/content/4/7/e005066
Updated information and services can be found at: 
These include:
Material
Supplementary
 066.DC1.html
http://bmjopen.bmj.com/content/suppl/2014/07/03/bmjopen-2014-005
Supplementary material can be found at: 
References
 #BIBLhttp://bmjopen.bmj.com/content/4/7/e005066
This article cites 29 articles, 15 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by-nc/3.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 3.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (267)Qualitative research
 (163)Patient-centred medicine
 (265)Paediatrics
 (947)Epidemiology
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on February 20, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
